Komipharm International

041960 · KOSDAQ · Health Care · SMALL CAP

Updated contract terms.

Komipharm International updated a previously disclosed supply contract with the Public Procurement Service, now worth US$4.51M, about 10.33% of its recent annual revenue, running through Sep 2027.

Supply contract([Amended] Supply contract signed)· FILED 2026-09-10· RCEPT 20260910900603

US$4.51MContract value
10.33%vs. recent revenue
Sep 2027Throughfrom Oct 2025

Converted at 1 USD ≈ ₩1,348.17 (filing-date rate, 2026-09-10 close)

What happened

Komipharm International updated a previously disclosed supply contract with the Public Procurement Service, now worth US$4.51M, about 10.33% of its recent annual revenue, running through Sep 2027.

For context, this single contract equals about 10.33% of the company's most recent annual revenue.

Counterpartythe Public Procurement Service
Contract valueUS$4.51M
vs. recent revenue10.33%
ThroughSep 2027 (from Oct 2025)
Filed2026-09-10, [Amended] Supply contract signed
SourceDART rcept 20260910900603 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-09-10 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.